Canadian application, no grantCanada
Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
CA 2506949 A1 · Owner: Altana Pharma Ag · Inventors: Schmidt, Mathias
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of a PDE4 or PDE3/4 inhibitor for the treatment of cachexia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 26, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 26, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 26, 2003
GrantedNo grant recorded
Term endedNovember 26, 2023
Patent numberCA 2506949 A1
Classification (IPC)A61K31/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.